CP-320626 is a potent inhibitor of human liver glycogen phosphorylase (IC50=205 nM). CP320626 reduces blood glucose in diabetic mice without changing plasma insulin levels. CP320626 can be used in the study of type 2 diabetes.
Specification: Moligand™, ≥98%
Molecular Formula: C23H23ClFN3O3
Molecular Weight: 443.90
PubChem CID: 444746
Isomeric SMILES: C1CN(CCC1O)C(=O)[C@H](CC2=CC=C(C=C2)F)NC(=O)C3=CC4=C(N3)C=CC(=C4)Cl
- UPC:
- 42251603
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- H668287-25mg
- CAS:
- 186430-23-9
- Product Size:
- 25mg
akash.verma@cenmed.com
(732) 447-1115





